SPOTLIGHT -
However, IOP remains most important risk factor for blindness
Foundation Fighting Blindness awards $900,000 to MitoChem Therapeutics to study target and mechanism of action in retinal degeneration disease
EyePod: Week in Review - September 10, 2023
Study: Researchers find new mechanisms that cause blindness, opening the door to future treatments
Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 4)
Macular leakage is important in diabetic eye disease outcomes
Navigating Ophthalmology's Changing Landscape with Insights from Stephen McLeod
